📊 JAMA Research Summary: Among adults with early symptomatic #AlzheimerDisease, ceperognastat did not slow clinical decline, and higher doses increased adverse event rates. #AAIC26 @alzassociation
📊 JAMA Research Summary: Among adults with early symptomatic #AlzheimerDisease, ceperognastat did not slow clinical decline, and higher doses increased adverse event rates. #AAIC26 @alzassociation
Read the full article3d agoen
You might also wanna read
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
clinicaltrials.gov·just now
Cervical and Mammogram Screenings, Walterboro - Monday, December 14, 2026
dph.sc.gov·just now
Cervical and Mammogram Screenings, Bluffton - Tuesday, December 1, 2026
dph.sc.gov·just now
Cervical and Mammogram Screenings, Varnville - Wednesday, October 21, 2026
dph.sc.gov·just now
Cervical and Mammogram Screenings, Goose Creek - Tuesday, September 8, 2026
dph.sc.gov·just now
Meta to notify parents when teens discuss suicide or self-harm with Instagram AI chatbot
gazeteoksijen.com·26m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.